HPV Vaccination and CIN3+ Among Women Aged 25–29 Years in Northern Norway, 2010–2024: A Population-Based Time-Series Analysis
As vaccinated birth cohorts-especially those vaccinated before sexual debut-entered organized screening at age 25, CIN3+ in women aged 25-29 years fell markedly. Estimates are based on coverage defined as ≥1 dose; future linkage to individual dose data and HPV type-specific CIN3+ is warranted.
Authors
- Mona Antonsen
- Sveinung Wergeland Sørbye (ORCID: https://orcid.org/0000-0002-8250-3992)
- Elin Mortensen
Institutions
- University Hospital of North Norway (NO)
- University of Inland Norway (NO)
Publication Details
- Journal
- Vaccines
- Published
- 2025-11-09
- DOI
- https://doi.org/10.3390/vaccines13111147
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35